Sunday, October 1, 2023

Latest:

An ounce of prevention: does breastfeeding protect against childhood cancer?
PARMESAN: An AI-based predictive tool to find new treatments for genetic disorders
What is a superfood?
Aortic dissection awareness saves lives: Understanding symptoms, causes, treatment options
Researchers combat Zika-associated fetal abnormalities using microRNA

Home
Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
Policywise
- About PolicyWise
- Follow @BCMEthics on Twitter
The Stitch
- About The Stitch
Progress Notes
bcm.edu

patent

From The Labs

From the labs to patent; osteoarthritis gene-therapy product is moving toward clinical trials

June 18, 2019June 18, 2019 clinical trial, gene therapy, Il-1, Osteoarthritis, patent, Research

More than 30 million people in the United States alone are affected by osteoarthritis (OA), a degenerative joint disease, and that number is expected to

Policywise

Licensing ‘CRISPR’ patents to promote public interests

January 18, 2017January 18, 2017 Center for Medical Ethics and Health Policy, Christi Guerrini, CRISPR, patent

Designer babies. Super soldiers. Unstable ecosystems. These are just a few of the feared outcomes from uncontrolled application of the new gene-editing technology known as

From the Labs: Plasticity of adult-born neurons.